Many of the gene regulatory networks used within the field of synthetic biology have extensively employed the AraC and LacI inducible transcription factors. However, there is no Escherichia coli strain that provides a proper background to use both transcription factors simultaneously. We have engineered an improved E. coli strain by knocking out the endogenous lacI from a strain optimal for AraC containing networks, and thoroughly characterized the strain both at molecular and functional levels. We further show that it enables the gradual and independent induction of both AraC and LacI in a simultaneous manner. This construct will be of direct use for various synthetic biology applications.
Introduction
Synthetic biology often deals with engineering of biological circuitry to obtain desired phenotypes. The successful design and construction of the first synthetic gene circuits like the genetic toggle switch [1] and the repressilator [2] have demonstrated that engineering-based methodology could indeed be used to build sophisticated, computing-like behavior into biological systems. Well-understood transcription factors are the key element for such circuits. Although many different transcription factors are found in nature, majority of them have not been well-characterized, and even their performance may be unpredictable [3] . Further, it is becoming evident that the host strain has a profound influence on the synthetic gene circuits phenotypic response [4] . Hence synthetic biology field has extensively used just a few well-characterized parts, in particular the arabinose operon regulator (AraC), lactose operon regulator (LacI), tetracycline operon regulator (TetR) and λ phage regulator (CI).
A plethora of E. coli strains is available to harbor synthetic regulatory networks built from TetR and CI parts, owing to their exogenous nature. However, the choice is limited for the networks that use the LacI and AraC parts, as they are endogenous to E. coli. Currently, there are~80 strains available with a lacI mutation at the coli genetic stock center, which may in principle be used to harbor constructs with the LacI, TetR and CI. For applications that aim to combine the AraC and LacI, one may consider strains KL390 (CGSC#6207), KL384 (CGSC#6205) and KL385 (CGSC#6206), since they have mutations in both the araC and lacI. However, these strains lead to an all-or-none response by the araBAD promoter (P BAD ), in which cells either display full expression or only basal expression, while gradual induction cannot be achieved, especially at the low concentration of the L-Arabinose inducer [5] . This all-or-none phenomena occurs because, expression of the inducer transporter is controlled by the inducer itself [5] . Additionally, these strains contain arabinose metabolizing genes, which results in the decrease of the effective concentration of L-Arabinose as the cells utilize it.
Here we constructed a host suitable for gene regulatory networks involving both the AraC and LacI transcription factors. We used the strain BW27783 (CGSC#12119) as a basis, since it carries a deletion for the arabinose metabolizing genes, and also abolished the all-or-none response, with a copy of the low-affinity high-capacity transporter, araE, under the control of an arabinose-independent promoter [6] . To allow for networks containing LacI as well, we knocked out the endogenous lacI copy from the BW27783 strain, using lambda Red recombinase mediated site-specific genome engineering technology [7] . We characterized the resulting new strain for the possible effects on the growth rate, and further show that it allows for the gradual and independent induction of AraC and LacI.
Results and discussion
The parent strain BW27783 carries a ΔlacZ4787(::rrnB-3) mutation, consisting of three tandem copies of rrnB transcriptional terminators inserted within the promoter of the lactose (lac) operon [6] . This suppresses the expression of lac operon, which was confirmed by the LacZ assay (see Additional file 1: Figure S1 ). Hence deletion of the lacI in this strain will not lead to the over expression of the lac operon.
We replaced the lacI with chloramphenicol acetyltransferase (cat) selection cassette in the parent strain BW27783, which resulted in the engineered strain MK01. We further confirmed the resulting lacI::cat replacement mutation in the MK01 strain by performing three independent PCR reactions ( Figure 1 ). The first reaction was carried out with the primer pair specific to the flanking regions of the inserted selection cassette that was not affected by the replacement mutation. Therefore, this primer set produced PCR amplicons with both the parental BW27783 as well as the engineered MK01 strains. The expected band size for BW27783 was 1209-base pairs (bps), whereas for MK01 it was 1123-bps, and the difference of 86-bps was quite evident on the gel (Figure 1b, left) . We further used the E. coli strain MC1061, as a negative control, which carries a complete deletion for lac operon, due to the mutation Δ(codB-lacI)3 [8] , thereby no PCR amplicons were produced (Figure 1b) . Additionally, two more PCR reactions were performed using the above flanking primers with an additional primers specific to the inserted selection cassette (Figure 1a, right) . These reactions produced amplicons only with the MK01 template as expected (Figure 1b , middle and right). Depending on the primer sets used, the expected band size was either1020-bps (Figure 1b, middle) or 850-bps (Figure 1b, right) . We further confirmed the lacI deletion by sequencing the genomic PCR amplicons from the MK01 template (data not shown). Sequencing results together with the PCR verification confirmed that lacI was successfully replaced by a selection cassette, with proven correct new junctions. We also chose to retain the cat resistance gene from the MK01 strain, as it serves as a good phenotypic marker for the lacI deletion mutation. When required, the selection cassette can be easily eliminated with the help of Cre recombinase, derived from a bacteriophage P1 that recombines the LoxP sites on either side of a selection cassette, thereby resulting in the excision of the selection cassette.
In order to further confirm the lacI deletion at the level of protein, we carried out Western blot analysis on both the parent and engineered strains (Figure 1c ). This confirms that the parent strain indeed expresses lacI repressor, as the protein was detected around 40 kilo Dalton (kDa). In particular, the engineered strain MK01 didn't Fluorescence intensity (a. u.) show any detectable protein around that size, confirming the complete knockout of the lacI repressor (Figure 1c) .
To assess the possible effects on the growth, we measured the relative accumulation of the parental and engineered cells in a stationary-phase culture. For this, we labeled these cells with two different fluorescent proteins (eYFP and mCherry), using constitutively expressing constructs (see Additional file 1: Figure S2a and b) , and performed competition experiment in M9 minimal medium. We initiated the competition by mixing equal densities of the cultures from both the strains and measured their relative abundance after 15 hours of the growth. This assay revealed that the engineered MK01 strain accumulated 5.6% less than the parent BW27783 strain (Figure 1d) . After swapping the fluorescent protein marker, MK01 again accumulated less than the parent strain (15.8%, Figure 1e ). These observations could be attributed to the constitutive expression of the cat selection cassette used to replace the lacI. Additionally, maintenance of the whole reporter plasmids used to label the strains may also influence the growth rates [9] . Furthermore, addition of the inducers L-Arabinose and Isopropyl β-D-1-thiogalactopyranoside (IPTG) did not show any differences in the relative accumulation, consistent with the idea that these inducers are nonmetabolizable (Figure 1d and e) .
Finally, to demonstrate the usefulness of the engineered MK01 strain in hosting the constructs involving both the AraC and LacI transcription factors simultaneously, we transformed this strain with the constructs on two different plasmids (see Additional file 1: Figure S3a and b) , in which the expression of mCherry and eYFP target reporter genes are regulated by these transcription factors. The data showed a gradual increase in the expression of the reporters with increasing concentrations of L-Arabinose and IPTG inducers (Figure 2 ). For this wide range of inducers concentrations, the population of cells responded homogeneously (Figure 2a) . Further, the AraC-controlled expression obtained at different concentrations of L-Arabinose remained same within the measurement error in both presence and absence of the LacI inducer IPTG (Figure 2b) . Similarly, the LacI-controlled expression obtained at different concentrations of IPTG was not influenced by the AraC inducer L-Arabinose. Thus, these transcription factors could be induced gradually and independently. Further our induction assay shows that AraC modulates the target gene expression up to 898-fold, whereas, LacI modulates its target gene up to 23-fold (Figure 2b ). Overall this demonstrates that our engineered MK01 E. coli strain is well-suited to study the gene regulatory networks involving both the AraC and LacI transcription factors simultaneously in a more quantitative manner.
Materials and method
The strain BW27783 (genotype: F-, Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), λ-, Δ(araH-araF)570(::FRT), ΔaraEp-532::FRT, φP cp8 -araE535, rph-1, Δ(rhaD-rhaB)568, hsdR514) [6] was used as a parental strain to derive the MK01 strain by following one-step inactivation of chromosomal genes procedure [7] . More detailed procedure on strain engineering can be found in the Additional file 1.
The expression of LacI protein was assayed by Western blotting using a mouse anti-LacI monoclonal antibody (Abcam), and a sheep anti-mouse secondary antibody (Jackson ImmunoResearch) conjugated to horseradish peroxidase.
Strains transformed with various DNA constructs (Additional file 1) were grown overnight in M9 minimal medium with appropriate antibiotics at 37°C. These cultures were further diluted to an optical density of 0.001 at 550 nm in the measuring plate. After 6 to 15 hours of further growth, cells were measured for fluorescence, using a BD LSRFortessa™ cell analyzer flow cytometer. The eYFP fluorescence was measured using a 488 nm excitation laser and a 515-545 nm emission filter, while mCherry was measured using a 561 nm excitation laser and 600-620 nm emission filter. A minimum of 10,000 cells was measured from each sample. From the single-cell fluorescence intensities, the mean fluorescence intensity per cell, representing the population average was calculated.
